Terumo Corp. said profit attributable to owners of the parent for the first quarter ended June 30 totaled ¥22.79 billion, a gain of 26% from ¥18.09 billion in the prior-year period.
EPS came in at ¥30.15, a 26.1% yearly increase from ¥23.91.
Revenue rose 6.6% year over year to ¥152.53 billion from ¥143.02 billion.
For fiscal year ending March 2020, the Japanese medical device maker expects profit attributable to owners of the parent to reach ¥81 billion, and revenue amounting to ¥635 billion.
Tokyo-based Terumo develops, manufactures and distributes medical devices and services worldwide.
As of Aug. 7, US$1 was equivalent to ¥105.70.